Clinical Trial Update: Pharmacokinetics and Pharmacodynamics of Intravenous Paracetamol in Morbidly Obese and Non- Obese Patients.

View source ↗

Summary

This clinical trial assesses the pharmacokinetics and pharmacodynamics of intravenous paracetamol in morbidly obese and non-obese individuals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acetaminophen Toxicity
• Morbid Obesity

Drugs mentioned

• Paracetamol (intravenous) (acetaminophen)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Acetaminophen Toxicity, Obesity, Morbid | Status: RECRUITING